Publication:

FDA and Social Media: The Impact of Social Media on Prescription Drug Advertising

Loading...
Thumbnail Image

Date

2011

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Kassity Yefei Liu, FDA and Social Media: The Impact of Social Media on Prescription Drug Advertising (September 2011).

Abstract

The U.S. Food and Drug Administration (FDA) regulates the promotion of prescription drugs. With the emergence of Web 2.0 technology and social media, the FDA faces new regulatory challenges as pharmaceutical companies have started to use social media tools to market prescription drugs to consumers. This paper first explores the history of social media, its use by the FDA, and its growing use by the pharmaceutical industry. The paper then discusses some of the actions that the agency has taken to respond to the industry’s use of social media. Lastly, the paper takes a look at the FDA’s repeated delays in issuing social media guidance, and discusses some of the “social media guidance” that pharmaceutical companies have received from other individuals and groups.

Description

Other Available Sources

Research Data

Keywords

human drugs>>prescription drug promotion>>physician advertising

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories

Story
FDA and Social Media: The Impact… : DASH Story 2013-02-04
I am a retired researcher and do not have access to many scholarly journals unless I pay myself. Open access is invaluable!!!